Chronic erythema nodosum leprosum in Hansen's disease: a challenging clinical management.
Michele Spinicci, Anna Barbiero, Tommaso Manciulli et al.
✦ AI-curated · Sources linked
Case in brief
A 34-year-old Moroccan man with multibacillary Hansen’s disease developed chronic erythema nodosum leprosum (ENL), with recurrent systemic and cutaneous flares requiring prolonged immunomodulatory treatment. Corticosteroids, thalidomide, azathioprine, methotrexate, and anti-TNF-α therapy each provided incomplete control. After six years of recurrent disease and several hospitalizations, a regimen of methylprednisolone, high-dose thalidomide, and clofazimine achieved sustained remission, permitting gradual discontinuation of treatment.
What made this case unusual
Despite trials of multiple immunomodulatory agents, including anti-TNF-α therapy, control remained incomplete until the combination of methylprednisolone, high-dose thalidomide, and clofazimine was used.
Diagnostic / clinical pearl
Chronic ENL can remain difficult to control despite several immunomodulatory approaches; this case describes sustained remission with combined methylprednisolone, high-dose thalidomide, and clofazimine.